These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10516392)

  • 21. Indomethacin and renal impairment in neonates.
    Akima S; Kent A; Reynolds GJ; Gallagher M; Falk MC
    Pediatr Nephrol; 2004 May; 19(5):490-3. PubMed ID: 15007713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of indomethacin on cerebral blood-flow velocity in premature infants.
    Evans DH; Levene MI; Archer LN
    Dev Med Child Neurol; 1987 Dec; 29(6):776-82. PubMed ID: 3691977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation between infusion rate of indomethacin and cerebral blood flow velocity.
    Kondo M; Kunikata T; Okazaki K; Yasuda S; Isobe K; Itoh S
    Pediatr Int; 2010 Aug; 52(4):616-21. PubMed ID: 20337980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary ET-1, AVP and sodium in premature infants treated with indomethacin and ibuprofen for patent ductus arteriosus.
    Zanardo V; Vedovato S; Lago P; Trevisanuto D; Favaro F; Faggian D; Plebani M
    Pediatr Nephrol; 2005 Nov; 20(11):1552-6. PubMed ID: 16133044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional cerebral blood flow velocity changes after indomethacin infusion in preterm infants.
    Austin NC; Pairaudeau PW; Hames TK; Hall MA
    Arch Dis Child; 1992 Jul; 67(7 Spec No):851-4. PubMed ID: 1519988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of indomethacin for patent ductus arteriosus in full-term infants.
    Takami T; Yoda H; Kawakami T; Yamamura H; Nakanishi T; Nakazawa M; Takei Y; Miyajima T; Hoshika A
    Pediatr Cardiol; 2007; 28(1):46-50. PubMed ID: 17203336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terlipressin-induced modifications of Doppler ultrasound signals of systemic arteries in preterm infants with vasoactive-resistant patent ductus arteriosus: A pilot study.
    Radicioni M; Bini V; Campus GM; Camerini PG
    J Clin Ultrasound; 2018 Mar; 46(3):202-208. PubMed ID: 29193158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late closure of the ductus arteriosus using indomethacin in the preterm infant.
    Kresch MJ; Moya FR; Ascuitto RJ; Ross-Ascuitto NT; Heusser F
    Clin Pediatr (Phila); 1988 Mar; 27(3):140-3. PubMed ID: 3342597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of prophylactic low-dose indomethacin on hemodynamics in very low birth weight infants.
    Yanowitz TD; Yao AC; Werner JC; Pettigrew KD; Oh W; Stonestreet BS
    J Pediatr; 1998 Jan; 132(1):28-34. PubMed ID: 9469996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus.
    Hsu JH; Yang SN; Chen HL; Tseng HI; Dai ZK; Wu JR
    J Pediatr; 2010 Jul; 157(1):79-84. PubMed ID: 20227723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indomethacin impairs coronary perfusion in infants with hemodynamically significant ductus arteriosus.
    Sehgal A; Ramsden CA; McNamara PJ
    Neonatology; 2012; 101(1):20-7. PubMed ID: 21791936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dopplersonographic findings in neonates with significant persistent ductus arteriosus].
    Robel-Tillig E; Knüpfer M; Pulzer F; Vogtmann C
    Z Geburtshilfe Neonatol; 2002 Apr; 206(2):51-6. PubMed ID: 12015635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of patent ductus arteriosus (PDA) using ibuprofen: renal side-effects in VLBW and ELBW newborns.
    Bagnoli F; Rossetti A; Messina G; Mori A; Casucci M; Tomasini B
    J Matern Fetal Neonatal Med; 2013 Mar; 26(4):423-9. PubMed ID: 23057804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Renal effects of prolonged indomethacin therapy in premature infants].
    Gouyon JB; Chouchane M; Françoise M
    Arch Pediatr; 1994 Oct; 1(10):894-7. PubMed ID: 7842069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indomethacin therapy in premature infants with patent ductus arteriosus--determination of therapeutic plasma levels.
    Yeh TF; Achanti B; Patel H; Pildes RS
    Dev Pharmacol Ther; 1989; 12(4):169-78. PubMed ID: 2766920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ibuprofen and indomethacin on urinary antidiuretic hormone excretion in preterm infants treated for patent ductus arteriosus.
    Zanardo V; Vedovato S; Lago P; Piva D; Faggian D; Chiozza L
    Fetal Diagn Ther; 2005; 20(6):534-9. PubMed ID: 16260891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of the patent ductus arteriosus: when, how, and for how long?
    Noori S; Seri I
    J Pediatr; 2009 Dec; 155(6):774-6. PubMed ID: 19914428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.